Your browser doesn't support javascript.
loading
Alternating venetoclax/azacytidine and FLT3 inhibitor treatment for NPM1- and FLT3-mutated acute myeloid leukemia.
Oya, Shuki; Ozawa, Hidetoshi; Maehiro, Yoshimi; Nakamura, Takayuki; Takaki, Yusuke; Fukuyama, Toshinobu; Yamasaki, Yoshitaka; Yamaguchi, Maki; Aoyama, Kazutoshi; Mouri, Fumihiko; Nagafuji, Koji.
Afiliação
  • Oya S; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Ozawa H; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Maehiro Y; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Nakamura T; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Takaki Y; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Fukuyama T; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Yamasaki Y; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Yamaguchi M; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Aoyama K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Mouri F; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. Electronic address: knagafuji@med.kurume-u.ac.jp.
Leuk Res ; 130: 107313, 2023 07.
Article em En | MEDLINE | ID: mdl-37207502

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article